Empowering Patients
Enable Injections, headquartered in Cincinnati, Ohio, is at the forefront of revolutionizing drug delivery. Led by Mike Hooven, a seasoned innovator in medical devices, the company has developed enFuse®, a groundbreaking wearable injector. This discreet device enables patients to self-administer high-volume medications (5 to 25 mL), providing increased comfort and convenience with an at-home treatment option.
The company’s vision is simple but transformative: empower patients while alleviating healthcare system pressures. With enFuse, patients may experience improved quality of life, and providers could benefit from potential reduced resource strain. By delivering innovation rooted in patient needs, Enable Injections is redefining the boundaries of medical care and positioning Ohio as a leader in life sciences.
Our mission has always been about making a positive impact on the patient experience. With enFuse, we’ve designed a solution that makes complex treatments simpler, giving patients the freedom to focus on living life while conveniently receiving treatment.
Mike HoovenPresident & CEO, Enable Injections
Strengthening Ohio’s Life Sciences Network
Enable Injections is deeply embedded in Ohio’s life sciences ecosystem, serving as both a contributor and a beneficiary. The company’s membership in Ohio Life Sciences (OLS) has offered invaluable opportunities to collaborate with industry leaders, access resources, and advocate for policies that foster innovation across the state.
Ohio Life Sciences has been a vital partner in our journey. They’ve created a platform that connects innovators and amplifies our collective impact, enabling companies like ours to thrive.
Mike HoovenPresident & CEO, Enable Injections
Enable Injections’ collaborations extend internationally, including partnerships with global pharmaceutical leaders such as Roche and Swedish Orphan Biovitrum AB (“Sobi”). These alliances not only highlight the company’s technical capabilities but also reinforce Ohio’s reputation as a hub for pioneering solutions that resonate on a global scale.
Looking Ahead: Pioneering New Frontiers
Enable Injections is actively preparing for its next phase of growth. With recent plans to expand manufacturing facilities and its corporate headquarters in Ohio, the company is doubling down on its commitment to the region. These expansions not only reflect confidence in local talent but also underscore the company’s belief in Ohio’s capacity to drive global innovation.
The potential applications for enFuse continue to grow, with the company exploring its use for a wider range of therapies. By addressing critical challenges in drug delivery, Enable Injections aims to remain at the forefront of patient-centered care while further strengthening Ohio’s leadership in the life sciences sector.
The future is about more than growth. It’s about redefining what’s possible in patient care. Ohio has given us the tools to push boundaries, and we’re excited to build on this foundation to deliver even greater impact.
Mike HoovenPresident & CEO, Enable Injections
Enable Injections stands as a shining example of the transformative power of innovation in healthcare. Its commitment to improving lives, coupled with its contributions to Ohio’s life sciences ecosystem, reflects a company poised for enduring success. As Enable Injections continues to grow and innovate, it sets a high bar for what can be achieved when technology, collaboration, and a focus on humanity come together.
